This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry June 10, 2025 By Christopher Cole News Article The dismissal of all 17 members of the Advisory Committee on Immunization Practices has far-reaching impacts for the industry and beyond. On June 9, 2025, Secretary of Health and Human Services Robert F. June 9, 2025.
The worldwide pharmaceutical container packaging market is expected to rise in revenue from $104.12 billion in 2025 to approximately $174.45 billion by 2033, according to a study published by Towards Packaging. Specifically, the “high quality of biodegradable and recyclable packaging materials” are driving the market.
CPHI Europe, reportedly, the world’s largest pharmaceutical event, will return to Messe Frankfurt from October 28-30, 2025. The event will gather the entire supply chain, including ingredients, finished dosages, machinery, bio, and packaging. CPHI events highlight industry trends, with analysts predicting growth in 2025.
Morepen Laboratories has announced the launch of four new productsTicapen, UdoFix, LycoMore, and Acifix Raftin April 2025 for the Indian market. These launches form part of Morepens broader strategy to enhance its finished dosages segment while leveraging its internal research and development (R&D) capabilities.
European geopolitical shifts In two installments of Pharmaceutical Technology ®’s “Industry Outlook 2025” series, Alexander Seyf, CEO and co-founder of Autolomous, and Edwin Stone, CEO of Cellular Origins, discussed European political impacts on the pharmaceutical industry at large, and the pharma supply chain in particular. June 12, 2025.
The second facility for WuXi STA in the US, Phase I of the new campus will provide formulation development, clinical and commercial drug product manufacturing services for a variety of oral and injectable dosage forms, as well as packaging, labelling, storage and distribution services for clinical trial materials and commercial drug products.
Biosimilars continue to build as a sector of this market with an estimated 2025 value in the region of US$42 billion (1). Mordorintelligence.com (accessed May 5, 2025). With their technical and methodological improvements, advanced techniques provide valuable information on overall product mass profiles. References Mordor Intelligence.
And in March 2025, Simtra head of Development Services Lidia Serina, PhD, spoke with Pharmaceutical Technology ® Group at the Drug, Chemical & Associated Technologies Association (DCAT) Week 2025 about the key challenges in aseptic processing for sterile injectables. June 11, 2025. June 10, 2025. Press Release.
Challener News Article Pharmaceutical Technology Pharmaceutical Technology June 2025 Volume 49 Issue 5 Unique surface properties and ligand functionalization provide real advantages. 2025 19 (4). Efficient and effective delivery of complex and challenging drug substances is an ongoing issue facing developers of modern medicines.
Moving and shaking The deal, approved unanimously by the boards of both companies, is expected to close in 2025, pending customary regulatory clearances and a minimum 80% share acceptance rate from CureVac shareholders—although BioNTech retains the option to reduce this threshold to 75% (1). June 12, 2025. billion (1). billion (1).
The global biopharma industry is expected to increase at a compound annual growth rate of 8.97% from 2025 to 2030; this growth is suspected to result from a demand for targeted therapies, new alliances, and increased innovation (1). Grandviewresearch.com (accessed May 19, 2025). Next-Generation Biotherapeutics eBook 2025 April.
June 11, 2025. ELK1 (accessed June 11, 2025). Major Depression (accessed June 11, 2025). Elkedonia Closes EUR 11 Million Seed Round to Advance Neuroplastogens as Novel Therapeutics for Depression and Neuropsychiatric Disorders. Press Release. National Institute of Mental Health.
Injectables and their packaging requirements have never been more important to marketed treatments, given the volume of vaccines being packaged that are required to tackle the Covid-19 pandemic, as well as the rising presence of biologics in pipelines and their marketed approvals. with BARDA (Washington DC).
While it’s uncommon for people without celiac disease to completely stop taking thyroid medication solely by going gluten free, some do find they can reduce their dosage through a gluten-free diet. You can learn about the top probiotics that I recommend at the linked to article, along with dosage info and precautions.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content